Gender-associated differences in metabolic syndrome-related parameters in Göttingen Minipigs

Comparative Medicine

Volumn 57, Issue 5, 2007, Pages 493-504

  Christoffersen, Berit Oestergaard ^a,b   Grand, Nanna ^c   Golozoubova, Valeria ^b   Svendsen, Ove ^a   Raun, Kirsten ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c Ellegaard Minipigs ApS ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; ESTRADIOL; FATTY ACID; FRUCTOSAMINE; GLUCAGON; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BODY WEIGHT; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MINIPIG; NONHUMAN; OBESITY; SEX DIFFERENCE; ANIMAL; BLOOD; BODY FAT DISTRIBUTION; COMPARATIVE STUDY; DISEASE MODEL; HUMAN; METABOLISM; SWINE;

ANIMALS; BIRTH WEIGHT; BODY FAT DISTRIBUTION; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; GLUCOSE; HUMANS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; SEX FACTORS; SWINE; SWINE, MINIATURE; TESTOSTERONE;

EID: 38449097784     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Academy for Gender-specific Medicine and Ageing. 2007. [Internet]. Available from: http://www.gendermedicine.com.
2. Alberti KG, Zimmet PZ. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553.
3. Arfai K, Pitukcheewanont PD, Goran MI, Tavare CJ, Heller L, Gilsanz V. 2002. Bone, muscle, and fat: sex-related differences in prepubertal children. Radiology 224:338-344.
4. Assmann G, Schulte H. 1992. The importance of triglycerides: results from the prospective cardiovascular Münster (PROCAM) study. Eur J Epidemiol 8 Suppl 1:99-103.
5. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B, -European GFTSOIR. 2002. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28:364-376.
6. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. 1993. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension, and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67.
7. Björntorp P. 1996. Growth hormone, insulin-like growth factor I, and lipid metabolism: interactions with sex steroids. Horm Res 46:188-191.
8. Bollen P, Ellegaard L. 1997. The Göttingen minipig in pharmacology and toxicology. Pharmacol Toxicol 80 Suppl 2:3-4.
9. Bollen PJA. 2001. Nutrition of Göttingen minipigs. A study of the influence of ad libitum and restricted feeding on the physiology of the Göttingen minipig [dissertation]. Odense (Denmark): Faculty of Health Sciences, University of Southern Denmark.
10. Bollen PJA, Madsen LW, Meyer O, Ritskes-Hoitinga J. 2005. Growth differences of male and female Göttingen minipigs during ad libitum feeding: a pilot study. Lab Anim 39:80-93.
11. Brandt H, Möllers B. 1999. Inzuchtdepression bei merkmalen der fruchtbarkeit und der gewichtsenrwicklung beim Göttinger miniaturschwein. Archiv fèur Tierzucht 42:601-610.
12. Brunner D, Weisbort J, Meshulam N, Schwartz S, Gross J, Saltz-Rennert H, Altman S, Loebl K. 1987. Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol 59:1271-1276.
13. Brussaard HE, Gevers-Leuven JA, Frölich M, Kluft C, Krans HM. 1997. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40:843-849.
14. Caprio S, Tamborlane WV, Silver D, Robinson C, Leibel R, McCarthy S, Grozman A, Belous A, Maggs D, Sherwin RS. 1996. Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol. 271:E626-E630.
15. Christoffersen B. 2007. Unpublished data.
16. Clapper JA, Clark TM, Rempel LA. 2000. Serum concentrations of IGF-I, estradiol-17beta, testosterone, and relative amounts of IGF binding proteins (IGFBP) in growing boars, barrows, and gilts. J Anim Sci 78:2581-2588.
17. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K, Pedersen O. 1996. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98:1195-1209.
18. Connor SL, Connor WE, Sexton G, Calvin L, Bacon S. 1982. The effects of age, body weight and family relationships on plasma lipoproteins and lipids in men, women, and children of randomly selected families. Circulation 65:1290-1298.
19. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl J Med 334:292-295.
20. Coppack SW, Frayn KN, Humphreys SM, Dhar H, Hockaday TD. 1989. Effects of insulin on human adipose tissue metabolism in vivo. Clin Sci (Lond) 77:663-670.
21. Desai K, Hollenberg CH. 1975. Regulation, by insulin, of lipoprotein lipase and phosphodiesterase activities in rat adipose tissue. Isr J Med Sci 11:540-550.
22. Dicker A, Rydén M, Näslund E, Muehlen IE, Wirén M, Lafontan M, Arner P. 2004. Effect of testosterone on lipolysis in human preadipocytes from different fat depots. Diabetologia 47:420-428.
23. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. 2006. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56:35-45.
24. Elbers JMH, Asscheman H, Seidell JC, Frolich M, Meinders AE, Gooren LJG. 1997. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab 82:3267-3270.
25. Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D'Alessio DA. 2006. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J Clin Endocrinol Metab 91:185-191.
26. Ferré P, Leturque A, Burnol A-F, Penicaud L, Girard J. 1985. A method to quantify glucose utilization in vivo in skeletal muscles and white adipose tissue in the anaesthetized rat. Biochem J 228:103-110.
27. Freeman MS, Mansfield MW, Barrett JH, Grant PJ. 2002. Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med 19:994-999.
28. Garaulet M, Pérez-Llamas F, Fuente T, Zamora S, Tebar FJ. 2000. Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol 143:657-666.
29. Glodek P. 1981. Entstehung und züchterische fortentwicklung. Glodek P, Oldigs B. Das Göttinger miniaturschwein. Berlin: Verlag Paul Parey. p 9-11.
30. Glümer C, Jørgensen T, Borch-Johnsen K, Inter99 study. 2003. Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 Study. Diabetes Care 26:2335-2340.
31. Goldberg RB, Rabin D, Alexander AN, Doelle GC, Getz GS. 1985. Suppression of plasma testosterone leads to an increase in serum total and high-density lipoprotein cholesterol and apoproteins A-I and B. J Clin Endocrinol Metab 60:203-207.
32. Gutai J, LaPorte R, Kuller L, Dai W, Falvo-Gerard L, Caqqiula A. 1981. Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am J Cardiol 48:897-902.
33. Haffner SM, Mykkänen L, Robbins D, Valdez R, Miettinen H, Howard BV, Stern MP, Bowsher R. 1995. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 38:1328-1336.
34. Hales CN, Barker DJ. 1992. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35:595-601.
35. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. 1991. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J (Clin Res Ed) 303:1019-1022.
36. Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. 1996. Gender differences in plasma leptin concentrations. Nat Med 2:949-950.
37. Henderson KK, Rector RS, Liu Y, Thomas TR, Turk JR, Laughlin MH, Sturek M. 2004. Trans fat increases total/HDL cholesterol ratio in a porcine model of cardiovascular disease. FASEB J 18:Abstract 384.2
38. Hu D, Hannah J, Gray RS, Jablonski KA, Henderson JA, Robbins DC, Lee ET, Welty TK, Howard BV. 2000. Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: the strong heart study. Obes Res 8:411-421.
39. Jacobsson L. 1989. Comparison of experimental hypercholesterolemia and atherosclerosis in male and female minipigs of the Gottingen strain. Artery 16:105-117.
40. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. 1998. Triglyceride concentration and ischemic-heart-disease - an 8-year follow-up in the Copenhagen male study. Circulation 97:1029-1036.
41. Johansen T, Hansen HS, Richelsen B, Malmlof K. 2001. The obese Gottingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile. Comp Med 51:150-155.
42. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. 1999. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 99:1165-1172.
43. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D. 1993. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672.
44. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D. 1994. The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43:587-592.
45. Kinosian B, Glick H, Garland G. 1994. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 121:641-647.
46. Kjems LL, Kirby BM, Welsh EM, Veldhuis JD, Straume M, McIntyre SS, Yang D, Lefèbvre P, Butler PC. 2001. Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes 50:2001-2012.
47. Krotkiewski M, Björntorp P, Sjöström L, Smith U. 1983. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 72:1150-1162.
48. Kumagai S, Holmäng A, Björntorp P. 1993. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 149:91-97.
49. Laakso M, Sarlund H, Mykkänen L. 1990. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223-231.
50. Labropoulos B, Velonakis E, Oekonomakos P, Laskaris J, Katsimades D. 1982. Serum sex hormones in patients with coronary disease and their relationship to known factors causing atherosclerosis. Cardiology 69:98-103.
51. Larsen MO, Juhl CB, Porksen N, Gotfredsen CF, Carr RD, Ribel U, Wilken M, Rolin B. 2005. Beta-Cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs. Am J Physiol Endocrinol Metab 288:E412-E421.
52. Larsen MO, Rolin B, Wilken M, Carr RD, Svendsen O. 2002. High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Göttingen minipig: results from a pilot study. Ann N Y Acad Sci 967:414-423.
53. Larsen MO, Rolin B, Wilken M, Carr RD, Svendsen O, Bollen P. 2001. Parameters of glucose and lipid metabolism in the male Göttingen minipig: influence of age, body weight, and breeding family. Comp Med 51:436-442.
54. Larsen MO, Wilken M, Gotfredsen CF, Carr RD, Svendsen O, Rolin B. 2002. Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab 282:E1342-E1351.
55. Laskarzewski PM, Rao DC, Glueck CJ. 1984. The Cincinnati lipid research clinic family study: analysis of comingling and family resemblance for fasting blood glucose. Genet Epidemiol 1:341-355.
56. Law CM, Barker DJ, Osmond C, Fall CH, Simmonds SJ. 1992. Early growth and abdominal fatness in adult life. J Epidemiol Community Health 46:184-186.
57. Legato MJ. 1997. Gender-specific physiology - how real is it - how important is it. Int J Fertil Womens Med 42:19-29.
58. Legato MJ. 2000. Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy. Am J Cardiol 86:15L-18L.
59. Legato MJ, Gelzer A, Goland R, Ebner SA, Rajan S, Villagra V, Kosowski M. 2006. Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 3:131-158.
60. Margolis CF, Sprecher DL, Simbartl LA, Campaigne BN. 1996. Male-female differences in the relationship between obesity and lipids/lipoproteins. Int J Obes Relat Metab Disord 20:784-790.
61. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419.
62. Molgaard-Hansen F, Fahmy N, Hoiriis-Nielsen J. 1980. The influence of sexual hormones on lipogenesis and lipolysis in rat fat cells. Endocrinology 95:566-570.
63. Morrison JA, Sprecher DL, Biro FM, Apperson-Hansen C, Lucky AW, DiPaola LM. 2000. Estradiol and testosterone effects on lipids in black and white boys aged 10 to 15 years. Metabolism 49:1124-1129.
64. Nagy TR, Gower BA, Trowbridge CA, Dezenberg C, Shewchuk RM, Goran MI. 1997. Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children. J Clin Endocrinol Metab 82:2148-2152.
65. Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B. 2003. Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50-57.
66. Niemelä O, Parkkila S, Pasanen M, Viitala K, Villanueva JA, Halsted CH. 1999. Induction of cytochrome P450 enzymes and generation of protein-aldehyde adducts are associated with sex-dependent sensitivity to alcohol-induced liver disease in micropigs. Hepatology 30:1011-1017.
67. Oh JY, Hong YS, Sung YA, Barrett-Connor E. 2004. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 27:2027-2032.
68. Onat A, Hergenc G, Keles I, Dogan Y, Turkmen S, Sansoy V. 2005. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome: prospective study of a cohort with normal glucose metabolism. Metabolism 54:800-808.
69. Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, Woodward M, Asia Pacific Cohort Studies Collaboration. 2004. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 110:2678-2686.
70. Pérusse L, Després JP, Tremblay A, Leblanc C, Talbot J, Allard C, Bouchard C. 1989. Genetic and environmental determinants of serum lipids and lipoproteins in French Canadian families. Arteriosclerosis 9:308-318.
71. Phillips GB. 1976. Evidence for hyperestrogenemia as a risk factor for myocardial infarction in men. Lancet 2:14-18.
72. Phillips GB, Jing T, Heymsfield SB. 2003. Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 52:784-790.
73. Pocock SJ, Shaper AG, Phillips AN. 1989. Concentrations of high-density lipoprotein cholesterol, triglycerides and total cholesterol in ischemic heart disease. Br Med J 298:998-1002.
74. Polderman KH, Gooren LJ, Asscheman H, Bakker A, Heine RJ. 1994. Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79:265-271.
75. Pouliot MC, Desprès JP, Nadeau A, Moorjani S, Prud'homme D, Lupien PJ, Tremblay A, Bouchard C. 1992. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834.
76. Raun K, Voss P, Knudsen L. 2007. Liraglutide, a long-acting GLP-1 analog, minimizes food intake in morbidly obese minipigs. Obesity (Silver Spring) 7:1710-1716.
77. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. 2006. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 95:136-147.
78. Roemmich JN, Clark PA, Berr SS, Mai V, Mantzoros CS, Flier JS, Weltman A, Rogol AD. 1998. Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids. Am J Physiol 275:E543-E551.
79. Rönnemaa TMJ, Savolainen MJ, Kesäniemi YA, Ehnholm C, Bouchard C, Koskenvuo M. 2006. Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity. J Clin Endocrinol Metab 83:2792-2799.
80. Ross R, Fortier L, Hudson R. 1996. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin, and glucose levels in obese women. Diabetes Care 19:1404-1411.
81. Shi K, Mizuno A, Sano T, Ishida K, Shima K. 1994. Sexual difference in the incidence of diabetes mellitus in Otsuka-Long-Evans-Tokushima- fatty rats: effects of castration and sex hormone replacement on its incidence. Metabolism 43:1214-1220.
82. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RDG. 2001. HbA(1c) levels are genetically determined even in type 1 diabetes - evidence from healthy and diabetic twins. Diabetes 50:2858-2863.
83. Srinivasan SR, Sundaram GS, Williamson GD, Webber LS, Berenson GS. 1985. Serum lipoproteins and endogenous sex hormones in early life: observations in children with different lipoprotein profiles. Metabolism 34:861-867.
84. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. 2000. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. J Am Med Assoc 284:311-318.
85. Stefanick ML, Williams PT, Krauss RM, Terry RB, Vranizan KM, Wood PD. 1987. Relationships of plasma estradiol, testosterone, and sex hormone-binding globulin with lipoproteins, apolipoproteins, and high-density lipoprotein subfractions in men. J Clin Endocrinol Metab 64:723-729.
86. Thomas TR, Pellechia J, Rector RS, Sun GY, Sturek MS, Laughlin MH. 2002. Exercise training does not reduce hyperlipidemia in pigs fed a high-fat diet. Metabolism 51:1587-1595.
87. Velle W. 1976. Endogenous anabolic agents in farm animals. Environmental quality and safety. Environ Qual Saf Suppl 5:159-170.
88. Welborn TA, Stenhouse NS, Johnstone CG. 1969. Factors determining serum-insulin response in a population sample. Diabetologia 5:263-266.
89. Williams JW, Zimmet PZ, Shaw JE, de-Court, Cameron AJ, Chitson P, Tuomilehto J, Alberti KGMM. 2003. Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabet Med 20:915-920.
90. Witczak CA, Mokelke EA, Boullion R, Wenzel J, Keisler DH, Sturek M. 2005. Noninvasive measures of body fat percentage in male Yucatan swine. Comp Med 55:445-151.
91. Xi S, Yin W, Wang Z, Kusunoki M, Lian X, Koike T, Fan J, Zhang Q. 2004. A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis. Int J Exp Pathol 85:223-231.
92. Yki-Jarvinen H. 1984. Sex and insulin sensitivity. Metabolism 33:1011-1015.
93. Yki-Järvinen H, Koivisto VA. 1983. Effects of body composition on insulin sensitivity. Diabetes 32:965-969.
94. Zierath JR, Livingston JN, Thörne A, Bolinder J, Reynisdottir S, Lönnqvist F, Arner P. 1998. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41:1343-1354.